THE EFFECTS OF EATING AND FASTING ON THE ABSORPTION OF METHYLPHENIDATEGUALTIERI CT; WARGIN W; KANOY R et al.1982; RES. COMMUN. PSYCHOL. PSYCHIATRIE BEHAV.; ISSN 0362-2428; USA; DA. 1982; VOL. 7; NO 3; PP. 381-384; BIBL. 2 REF.Article

The clinical pharmacokinetics of Vinorelbine (Navelbine)WARGIN, W. A; LUCAS, V. S.Seminars in oncology. 1994, Vol 21, Num 5, pp 21-27, issn 0093-7754, SUP10Conference Paper

CLINICAL STUDIES OF METHYLPHENIDATE SERUM LEVELS IN CHILDREN AND ADULTSGUALTIERI CT; WARGIN W; KANOY R et al.1982; J. AM. ACAD. CHILD PSYCHIATRY; ISSN 0002-7138; USA; DA. 1982; VOL. 21; NO 1; PP. 19-26; BIBL. 32 REF.Article

A normal phase HPLC method for the determination of two arylmethylamino-propanediols (AMPAs), crisnatol and 773U82 in plasmaHSIEH, A.-L. Y; BULKOWSKI, D. M; WARGIN, W. A et al.Journal of liquid chromatography. 1991, Vol 14, Num 14, pp 2735-2744, issn 0148-3919Article

Effect of duration of lidocaine infusion and route of cimetidine adminstration on lidocaine pharmacokineticsPOWELL, J. R; FOSTER, J; PATTERSON, J. H et al.Clinical pharmacy. 1986, Vol 5, Num 12, pp 993-998, issn 0278-2677Article

The pharmacokinetics of 1954U89, 1,3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3,2-f)quinazoline, in dogs and rats after intravenous and oral administrationSTUDENBERG, S. D; WOOLLEY, J. L; DEANGELIS, D. V et al.Biopharmaceutics & drug disposition. 1997, Vol 18, Num 5, pp 433-442, issn 0142-2782Article

Antipyrine kinetics following partial blood exchange with fluosol-DA in the ratSHREWSBURY, R. P; WHITE, S. G; POLLACK, G. M et al.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 12, pp 883-887, issn 0022-3573Article

Antipyrine kinetics following partial blood exchange with fluosol-DA in the ratSHREWSBURY, R. P; WHITE, S. G; POLLACK, G. M et al.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 12, pp 883-887, issn 0022-3573Article

Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacinWILLIAMS, P. J; HULL, J. H; SARUBBI, F. A et al.Journal of clinical pharmacology. 1986, Vol 26, Num 2, pp 79-86, issn 0091-2700Article

Influence of a continuous cimetidine infusion on lidocaine plasma concentrations in patientsPATTERSON, J. H; FOSTER, J; POWELL, J. R et al.Journal of clinical pharmacology. 1985, Vol 25, Num 8, pp 607-609, issn 0091-2700Article

Pharmacokinetics of methylphenidate in man, rat and monkeyWARGIN, W; PATRICK, K; KILTS, C et al.The Journal of pharmacology and experimental therapeutics. 1983, Vol 226, Num 2, pp 382-386, issn 0022-3565Article

Importance of the organ-independent elimination of cisatracuriumKISOR, D. F; SCHMITH, V. D; WARGIN, W. A et al.Anesthesia and analgesia. 1996, Vol 83, Num 5, pp 1065-1071, issn 0003-2999Article

Crisnatol mesylate : phase I dose escalation by extending infusion durationPOPLIN, E. A; CHABOT, G. G; TUTTLE, R. L et al.Investigational new drugs. 1991, Vol 9, Num 1, pp 41-47, issn 0167-6997, 7 p.Article

Pharmacokinetics of RheothRx Injection in healthy male volunteersJEWELL, R. C; KHOR, S. P; KISOR, D. F et al.Journal of pharmaceutical sciences. 1997, Vol 86, Num 7, pp 808-812, issn 0022-3549Article

Inhibition of theophylline clearance by cimetidine but not ranitidinePOWELL, J. R; ROGERS, J. F; WARGIN, W. A et al.Archives of internal medicine (1960). 1984, Vol 144, Num 3, pp 484-486, issn 0003-9926Article

Pharmacokinetics of oral and transdermal triprolidineMILES, M. V; BALASUBRAMANIAN, R; PITTMAN, A. W et al.Journal of clinical pharmacology. 1990, Vol 30, Num 6, pp 572-575, issn 0091-2700, 4 p.Article

Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesiaDRESNER, D. L; BASTA, S. J; ALI, H. H et al.Anesthesia and analgesia. 1990, Vol 71, Num 5, pp 498-502, issn 0003-2999, 5 p.Article

NDA day: the approval of a neuromuscular blocking agentMILLER, L; ABOU-DONIA, M; HUTSON, B et al.Journal of clinical research and pharmacoepidemiology. 1992, Vol 6, Num 4, pp 271-284, issn 1047-0336Article

The effects of food and divised dosing on the bioavailability of oral vinorelbineROWINSKY, E. K; SOL LUCAS, V; HSIEH, A.-L. Y et al.Cancer chemotherapy and pharmacology. 1996, Vol 39, Num 1-2, pp 9-16, issn 0344-5704Article

Bidirectional interaction of valproate and lamotrigine in healthy subjectsANDERSON, G. D; YAU, M. K; GIDAL, B. E et al.Clinical pharmacology and therapeutics. 1996, Vol 60, Num 2, pp 145-156, issn 0009-9236Article

Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsyRAMSAY, R. E; PELLOCK, J. M; OTTO, V et al.Epilepsy research. 1991, Vol 10, Num 2-3, pp 191-200, issn 0920-1211Article

Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleHARMAN, G. S; CRAIG, J. B; WARGIN, W et al.Cancer research (Baltimore). 1988, Vol 48, Num 16, pp 4706-4710, issn 0008-5472Article

Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleCOBB, P. W; HAVLIN, K. A; TUTTLE, R. L et al.Selective cancer therapeutics. 1991, Vol 7, Num 2, pp 85-91, issn 1043-0733Article

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose scheduleVON HOFF, D. D; KUHN, J. G; WARGIN, W et al.Cancer research (Baltimore). 1990, Vol 50, Num 23, pp 7496-7500, issn 0008-5472, 5 p.Article